Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lubomirov, Rubin
43  Ergebnisse:
Personensuche X
?
1

Pharmacokinetics and Safety of Lurbinectedin Administrated ..:

Moreno, Irene ; Hernández, Tatiana ; Calvo, Emiliano...
Marine Drugs.  22 (2024)  4 - p. 178 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinect..:

Moreno, Irene ; Hernández, Tatiana ; Calvo, Emiliano...
Pharmaceuticals.  17 (2024)  2 - p. 182 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Quantitative determination of lurbinectedin, its unbound fr..:

King, Nicholas ; Garcia-Martinez, Soledad ; Alcaraz, Eider...
PLOS ONE.  18 (2023)  3 - p. e0283783 , 2023
Link: https://doi.org/10.1371/..
 
?
4

A model-based head-to-head comparison of single-agent lurbi..:

Fudio, Salvador ; Pérez-Ramos, Laura ; Asín-Prieto, Eduardo..
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
5

A model-based head-to-head comparison of single-agent lurbi..:

Salvador Fudio ; Laura Pérez-Ramos ; Eduardo Asín-Prieto..
https://www.frontiersin.org/articles/10.3389/fonc.2023.1152371/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
6

Quantitative determination of lurbinectedin, its unbound fr..:

Nicholas King ; Soledad Garcia-Martinez ; Eider Alcaraz...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062662/?tool=EBI.  , 2023
Link: https://doaj.org/article..
 
?
7

Quantitative determination of lurbinectedin, its unbound fr..:

Nicholas King ; Soledad Garcia-Martinez ; Eider Alcaraz...
https://doi.org/10.1371/journal.pone.0283783.  , 2023
Link: https://doi.org/10.1371/..
 
?
8

DataSheet_1_A model-based head-to-head comparison of single..:

Salvador Fudio ; Laura Pérez-Ramos ; Eduardo Asín-Prieto..
doi:10.3389/fonc.2023.1152371.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
9

Anti-cancer drug combinations approved by US FDA from 2011 ..:

Fudio, Salvador ; Sellers, Alvaro ; Pérez Ramos, Laura...
Cancer Chemotherapy and Pharmacology.  90 (2022)  4 - p. 285-299 , 2022
Link: https://doi.org/10.1007/..
 
?
10

Preclinical and randomized phase I studies of plitidepsin i..:

Varona, José F ; Landete, Pedro ; López-Martín, José A...
Publisher's version.  , 2022
Link: http://hdl.handle.net/10..
 
?
11

Preclinical and randomized phase I studies of plitidepsin i..:

Varona, Jose F ; Landete, Pedro ; Lopez-Martin, Jose A...
Life Science Alliance.  , 2022
Link: https://ddd.uab.cat/reco..
 
?
12

Preclinical and randomized phase I studies of plitidepsin i..:

Varona, Jose F ; Landete, Pedro ; Lopez-Martin, Jose A...
Life Science Alliance.  , 2022
Link: https://hdl.handle.net/2..
 
?
13

Preclinical and randomized phase I studies of plitidepsin i..:

Varona, Jose F ; Landete, Pedro ; Lopez-Martin, Jose A...
qt5pg2r03w.  , 2022
Link: https://escholarship.org..
 
?
14

Integrated exposure–response analysis of efficacy and safet..:

Fernández-Teruel, Carlos ; Fudio, Salvador ; Lubomirov, Rubin
Cancer Chemotherapy and Pharmacology.  89 (2021)  5 - p. 585-594 , 2021
Link: https://doi.org/10.1007/..
 
?
15

Population Pharmacokinetic‐Pharmacodynamic Modeling and Cov..:

Fernández‐Teruel, Carlos ; Lubomirov, Rubin ; Fudio, Salvador
The Journal of Clinical Pharmacology.  61 (2021)  9 - p. 1206-1219 , 2021
Link: https://doi.org/10.1002/..
 
1-15